Fairfax Financial Holdings Limited (TSE:FFH - Free Report) - National Bank Financial decreased their Q1 2025 earnings per share estimates for Fairfax Financial in a report released on Tuesday, October 29th. National Bank Financial analyst J. Gloyn now anticipates that the company will post earnings per share of $55.92 for the quarter, down from their prior estimate of $56.17. The consensus estimate for Fairfax Financial's current full-year earnings is $212.30 per share. National Bank Financial also issued estimates for Fairfax Financial's Q2 2025 earnings at $51.71 EPS.
Other equities research analysts have also issued research reports about the company. National Bankshares raised their price objective on Fairfax Financial from C$2,100.00 to C$2,200.00 and gave the company an "outperform" rating in a research note on Wednesday. Scotiabank lifted their target price on Fairfax Financial from C$1,950.00 to C$2,000.00 in a research report on Wednesday, July 24th. Finally, Royal Bank of Canada lifted their target price on Fairfax Financial from C$1,325.00 to C$1,425.00 and gave the stock an "outperform" rating in a research report on Thursday, October 3rd.
Read Our Latest Stock Analysis on Fairfax Financial
Fairfax Financial Stock Down 1.3 %
TSE FFH traded down C$22.33 during mid-day trading on Thursday, reaching C$1,730.25. 33,491 shares of the company's stock traded hands, compared to its average volume of 54,520. Fairfax Financial has a 1-year low of C$1,138.41 and a 1-year high of C$1,771.00. The company has a fifty day simple moving average of C$1,675.30 and a 200-day simple moving average of C$1,585.26. The company has a current ratio of 3.75, a quick ratio of 0.93 and a debt-to-equity ratio of 40.13. The company has a market cap of C$40.33 billion, a price-to-earnings ratio of 7.70, a P/E/G ratio of 0.27 and a beta of 0.83.
Fairfax Financial (TSE:FFH - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported C$50.87 earnings per share for the quarter, missing analysts' consensus estimates of C$51.23 by C($0.36). Fairfax Financial had a net margin of 12.27% and a return on equity of 17.91%. The business had revenue of C$10.25 billion for the quarter.
Insider Buying and Selling at Fairfax Financial
In other Fairfax Financial news, Director Brian David Young sold 4,280 shares of Fairfax Financial stock in a transaction on Friday, August 30th. The stock was sold at an average price of C$1,617.96, for a total transaction of C$6,924,875.22. In other news, Director F. Brian Bradstreet sold 500 shares of the business's stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of C$1,629.00, for a total value of C$814,500.00. Also, Director Brian David Young sold 4,280 shares of the business's stock in a transaction on Friday, August 30th. The stock was sold at an average price of C$1,617.96, for a total value of C$6,924,875.22. Insiders have sold 6,953 shares of company stock valued at $11,304,176 in the last quarter. Corporate insiders own 3.76% of the company's stock.
About Fairfax Financial
(
Get Free Report)
Fairfax Financial Holdings Limited, through its subsidiaries, provides property and casualty insurance and reinsurance, and investment management services in the United States, Canada, Asia, and internationally. The company operates through Property and Casualty Insurance and Reinsurance, Life insurance and Run-off, and Non-Insurance Companies segments.
Further Reading
Before you consider Fairfax Financial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fairfax Financial wasn't on the list.
While Fairfax Financial currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.